Form D Explorer
AN2 Therapeutics, Inc. · CIK 1880438

Report a data issueCitable research briefCompare issuerPrivate research collection

AN2 Therapeutics, Inc.

CIK 1880438 · Corporation · Inc. DELAWARE · MENLO PARK, California · Pharmaceuticals

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
1
Original notices
1
Amendments
0
Activity
Mar 25, 2026
through Mar 25, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D · Mar 25, 2026

Reported offering amount
$39,999,989
Reported exemptions
Rule 506(b)
Reported amount sold
$39,999,989

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Same reported sales compensation recipient

Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.

Form D filings (1)